JAMUNA RAJU: Open Payments
NPI 1922290873 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,198 in 43 payments from 10 companies in 2025. Trend: 2023 $1,491 · 2024 $992 · 2025 $1,198
Food & beverage: $1,198
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $262 |
| Otsuka America Pharmaceutical, Inc. | 10 | $254 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $145 |
| Axsome Therapeutics, Inc. | 4 | $126 |
| Lundbeck LLC | 4 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| ABBVIE INC. | 3 | $77 |
| Alkermes, Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Bausch Health US, LLC | 1 | $22 |
Products named: REXULTI, HETLIOZ, CAPLYTA, TRINTELLIX, Auvelity, VRAYLAR, FANAPT, INGREZZA.
Industry payments across VA — which companies pay providers there.
